DNA ploidy is a stronger prognostic variable compared to microsatellite instability or 18q allelic loss in patients with stages II and III colon cancer
Year: 2005
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: F. A. Sinicrope, K. C. Halling, A. French, L. J. Burgart, N. Foster, D. J. Sargent, R. M. Goldberg, M. J. O’Connell, T. E. Witzig, S. N. Thibodeau
Institution: Mayo Clinic
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2591291697
